Rentokil Initial Shares Plummet 17% as North America Weakness Overshadows H1 Profit
Rentokil Initial's shares plunged by 17% despite solid first-half results, as investors were rattled by weaknesses in its North American business, particularly in residential lead flow and commercial revenue growth. The company scrapped its 2027 North America margin target to prioritize volume and reinvestment …